<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04627077</url>
  </required_header>
  <id_info>
    <org_study_id>2017-08-0081</org_study_id>
    <nct_id>NCT04627077</nct_id>
  </id_info>
  <brief_title>Livestrong Cancer Institutes' Patient Reported Outcomes Study</brief_title>
  <acronym>LCI PROs</acronym>
  <official_title>Livestrong Cancer Institutes' Patient Reported Outcomes Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas at Austin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas at Austin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study will be to collect baseline patient reported outcome measures at the&#xD;
      Livestrong Cancer Institutes (LCI) with the goal of improving quality care and to inform&#xD;
      decision making by patients, providers, and researchers for future LCI initiatives.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This proposed study is a descriptive study of the adult oncology population at the Seton&#xD;
      Infusion Center in order to provide information about patient needs and identify areas for&#xD;
      further research and resource allocation. The patient reported outcome measures being&#xD;
      collected cover the following domains: anxiety, depression, fatigue, physical function,&#xD;
      financial toxicity and pain. Patients and caregivers will be informed about the study and&#xD;
      given the opportunity to enroll at the time of routine clinic visits at the Dell Seton&#xD;
      Medical Center at The University of Texas Seton Infusion Center (SIC). Patients choosing to&#xD;
      enroll in the study will be provided informed consent, and then allowed to complete the&#xD;
      measures during their clinic visit on an iPad provided by the research staff. After IRB&#xD;
      approval for a period of 1-2 months data collection will take place at the SIC clinic at DMS.&#xD;
      Upon completion of the measures patients will be asked for an email address and phone number&#xD;
      so that a follow up link to survey questions can be sent to them in 3 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 22, 2018</start_date>
  <completion_date type="Actual">January 25, 2019</completion_date>
  <primary_completion_date type="Actual">January 25, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Quality of Life - FACT-G</measure>
    <time_frame>Baseline</time_frame>
    <description>Functional Assessment of Cancer Therapy (FACT-G)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Anxiety - PROMIS</measure>
    <time_frame>Baseline and 3 month follow up</time_frame>
    <description>PROMIS adaptive anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Depression - PROMIS</measure>
    <time_frame>Baseline and 3 month follow up</time_frame>
    <description>PROMIS adaptive Depression</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Pain - PROMIS</measure>
    <time_frame>Baseline and 3 month follow up</time_frame>
    <description>PROMIS adaptive pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Physical Function- PROMIS</measure>
    <time_frame>Baseline and 3 month follow up</time_frame>
    <description>PROMIS adaptive physical function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Fatigue - PROMIS</measure>
    <time_frame>Baseline and 3 month follow up</time_frame>
    <description>PROMIS adaptive fatigue</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Financial Toxicity</measure>
    <time_frame>Baseline and 3 month follow up</time_frame>
    <description>Comprehensive Score for financial Toxicity (COST) questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Patient satisfaction with care</measure>
    <time_frame>Baseline and 3 month follow up</time_frame>
    <description>The CAHPSÂ® Cancer Care Survey</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Impact on Caregivers</measure>
    <time_frame>Baseline and 3 month follow up</time_frame>
    <description>Brief Assessment Scale for Caregivers (BASC), range -27 to 12, higher scores poorer outcomes</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">121</enrollment>
  <condition>Neoplasms</condition>
  <condition>Drug Therapy</condition>
  <arm_group>
    <arm_group_label>SIC drug therapy patients</arm_group_label>
    <description>Patients with a cancer diagnosis currently being treated at SIC clinic</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Total sample size of 200 adult patients and caregivers (n=200 dyads). Patients are&#xD;
        currently receiving treatment for a cancer diagnosis at the Seton Infusion Center.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient aged 18 years and older, being treated for cancer at the Seton Infusion Clinic&#xD;
&#xD;
          -  Patient cognitively and physically able to complete questionnaires on an ipad in&#xD;
             English or Spanish.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  -Patient unable to speak English or Spanish as required for study data collection&#xD;
&#xD;
          -  Patient cognitively or physically unable to complete measures&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Dell Seton Medical Center</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>May 4, 2018</study_first_submitted>
  <study_first_submitted_qc>November 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2020</study_first_posted>
  <last_update_submitted>November 6, 2020</last_update_submitted>
  <last_update_submitted_qc>November 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas at Austin</investigator_affiliation>
    <investigator_full_name>Gail Eckhardt</investigator_full_name>
    <investigator_title>Director, LIVESTRONG Cancer Institutes Chair, Department of Oncology</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

